Cistanche Glyside Rg1 Ameliorates Aging‑induced Liver Fibrosis By Inhibiting The NOX4/NLRP3 Inflammasome in SAMP8 Mice
May 29, 2023
Abstract. Aging is often accompanied by liver injury and fibrosis, eventually leading to a decline in liver function. However, the mechanism of aging‑induced liver injury and fibrosis is still not fully understood, to the best of our knowledge, and there are currently no effective treatment options available for liver aging. Cistanche Glycoside Rg1 (Rg1) has been reported to exert potent anti‑aging effects due to its potent antioxidant and anti‑inflammatory activity. The present study aimed to investigate the protective effect and underlying mechanism of action of Rg1 in aging‑induced liver injury and fibrosis in senescence‑accelerated mouse prone 8 (SAMP8) mice treated for 9 weeks.

Click Here To Get More Info About Cistanche Anti-aging treatment for Liver
The histopathological results showed that the arrangement of hepatocytes was disordered, vacuole‑like degeneration occurred in the majority of cells, and collagen IV and TGF‑β1 expression levels, that were detected via immunohistochemistry, were also significantly upregulated in the SAMP8 group. Rg1 treatment markedly improved aging‑induced liver injury and fibrosis, and significantly downregulated the expression levels of collagen IV and TGF‑β1. In addition, the dihydro ethylene staining and western blotting results showed that Rg1 treatment significantly reduced the levels of reactive oxygen species (ROS) and IL‑1β, and downregulated the expression levels of NADPH oxidase 4 (NOX4), p47phox, p22phox, phosphorylated‑NF‑κB, caspase‑1, apoptosis‑asso‑ciated speck‑like protein containing a C‑terminal caspase recruitment domain and the NLR family pyrin domain containing 3 (NLRP3) inflammasome, which were significantly upregulated in the liver tissues of elderly SAMP8 mice. In conclusion, the findings of the present study suggest that Rg1 may attenuate aging‑induced liver injury and fibrosis by reducing NOX4‑mediated ROS oxidative stress and inhibiting NLRP3 inflammasome activation.

Introduction
Liver fibrosis is a dynamic process associated with the continuous deposition and resorption of the extracellular matrix, mainly fibrillar collagen (3), which is often the first step in architectural distortion and dysfunction that prevents the normal functioning of the liver (4). If untreated, liver fibrosis may lead to advanced liver cirrhosis and hepatoma (4). Accumulating evidence has suggested that susceptibility to liver fibrosis and hepatitis significantly increases with age (5). Thus, it remains of high importance to study liver aging and the associated underlying mechanisms to provide novel strategies to prevent aging‑related liver fibrosis.7
recognition receptor of caspase‑1 and apoptosis‑associated speck‑like protein containing a C‑terminal caspase recruitment domain (ASC). According to the finding of previous studies, the NLRP3 inflammasome, a type of inflammasome ubiquitously expressed in numerous tissues, including the liver, was discovered to be involved in the evolution of liver fibrosis and the progression of liver injury and age‑related liver disease (20‑22). When activated by diverse irritants, such as ATP and cholesterol crystals, as well as bacterial, viral and fungal pathogens (23,24), the NLRP3 inflammasome responds to inflammation by promoting the maturation of a series of proinflammatory cytokines, such as IL‑1β and IL‑18 (25). In addition, it has been reported that excessive ROS accumulation activated the NLRP3 inflammasome in the liver during the process of aging, eventually leading to aging‑associated liver disease (26).
Materials and methods
Animals and treatment. In total, 9 male senescence‑accelerated resistant mouse 1 (SAMR1) and 45 male SAMP8 mice (both age, 6 months; weight, 30‑40 g) were purchased from the Department of Experimental Animal Science, Peking University Medical Science Center (Beijing, China). The mice were maintained in an environmentally controlled room (temperature, 22‑25˚C; relative humidity, 50‑70%) under a 12‑h light/dark cycle with unlimited access to food and water. The SAMP8 mice were randomly divided into five groups (n=9 in each group): i) SAMP8 model group; ii) SAMP8 + apocynin (50 mg/kg) group; iii) SAMP8 + tempol (50 mg/kg) group; iv) SAMP8 + Rg1 (5 mg/kg) group; v) SAMP8 + Rg1 (10mg/kg) group; and vi) SAMR1 mice group, which were used as the control group. The treatments were administered intragastrically (0.1 ml/10 g body weight), and the mice treated with either apocynin (MilliporeSigma), tempol (MilliporeSigma) or Rg1 (content >98%; Chengdu Desite Biotechnology Co., Ltd.) once a day for 9 weeks. The SAMP8 and SAMR1 groups were treated with distilled water for 9 weeks. Following 9 weeks of treatment, six mice in each group were sacrificed via cervical dislocation. The livers were harvested and stored in at ‑80˚C for subsequent use in western blotting experiments, or placed

tome (Leica CM3050; Leica Microsystems GmbH) at ‑20˚C. The sections were washed with PBS and incubated with 5 mg/l Hoechst 33258 solution (Sigma‑Aldrich; Merck KGaA) at room temperature for 5 min. Then, the sections were sealed with an anti‑fluorescence quenching agent (Beyotime Institute of Biotechnology) and visualized using a fluorescence microscope (Olympus IX72; Olympus Corporation; magnification, x400). Image Pro Plus 6.0 software (Media Cybernetics, Inc.) was used to detect the average density of red fluorescence from three randomly selected fields of view in each section to indicate ROS production.
Pathological examination of the liver tissue.
The morphological changes in the liver were examined using H&E, periodic acid‑Schiff (PAS), and Masson's trichrome staining techniques. H&E staining is the most common method for observing pathological changes in tissues (38). Briefly, liver specimens were fixed in 4% paraformaldehyde for 24‑48 h, dehydrated and paraffin-embedded, then cut into 5‑µm thick sections. Liver sections (n=4) were deparaffinized in xylene and rehydrated in graded alcohol series (anhydrous ethanol, 85% ethanol, 75% ethanol), then stained with hematoxylin for 3 min and eosin for 30 sec. All these steps were carried out at room temperature. The sections were sealed with neutral resin and observed using a light microscope (Olympus IX72; Olympus Corporation; magnification, x200).
Immunohistochemistry staining.
The paraffin‑embedded sections (n=4) were deparaffinized and rehydrated, according to the method described for H&E staining. Then, the sections were incubated with 3% H2O2 for 10 min at 37˚C to block the endogenous peroxidase activity prior to being immersed in boiling sodium citrate buffer for 7 min in a microwave oven for antigen retrieval. The sections were subsequently incubated with 10% goat serum (cat. no. C0265; Beyotime Institute of Biotechnology) at 37˚C for 30 min to block non‑specific binding. The sections were then incubated with the following primary antibodies at 4˚C overnight: Rabbit polyclonal anti‑collagen IV (1:100; Bioworld Biotechnology,Inc.; cat. no. BS1072), rabbit polyclonal anti‑NLRP3 (1:100; Bioworld Biotechnology, Inc.; cat. no. BS90949) and rabbit polyclonal anti‑TGF‑β1 (1:100; Abcam; cat. no. ab92486).
Western blotting.
Total protein was extracted from liver tissues (n=3) using RIPA lysis buffer (cat. no. P0013B; Beyotime Institute of Biotechnology) and an automatic sample rapid grinding machine (Jinxing Industrial Development Co.,Ltd.) at 65 Hz for 60 sec at 4˚C. Total protein was quantified using a BCA protein assay kit and the proteins (20 µg) were separated via 8‑15% SDS/PAGE. The separated proteins were subsequently transferred onto PVDF membranes (MilliporeSigma) and blocked with 5% skimmed milk in TBS‑0.05% Tween‑20 (TBST) buffer for 1 h at room temperature. The membranes were then incubated with the following primary antibodies overnight at 4˚C: Anti‑NLRP3 (1:1,000; Bioworld Biotechnology, Inc.; cat. no. BS90949), anti‑ASC (1:1,000; BIOSS; cat. no. bs‑67412‑R), anti‑caspase‑1(1:1,000; Abcam; cat. no. ab1872), anti‑IL‑1β (1:500; Abcam;cat. no. ab9722), anti‑NOX4 (1:1,000; Bioworld Biotechnology,Inc.; cat. no. BS60435), anti‑p47phox (1:1,000; Bioworld Biotechnology, Inc.; cat. no. BS4852), anti‑p22phox (1:1,000;Bioworld Biotechnology, Inc.; cat. no. BS60290), anti‑NF‑κB p65 (1:1,000; Wuhan Service Technology Co., Ltd.;
Following the primary antibody incubation, the membranes were washed with TBST three times (10 min each time) and incubated with HRP‑conjugated goat anti‑rabbit IgG (1:10,000; Affinity Biosciences; cat. no. S0001) and goat anti‑mouse IgG (1:10,000 Affinity Biosciences; cat. no. S0002) secondary antibodies for 1 h at room temperature. Protein bands were visualized using an ECL kit (Bio‑Rad Laboratories, Inc.) and a Bioshine Chemi Imaging System (Q4600 Mini; Shanghai Bioshine Technology). The optical density of each band was semi‑quantified using ImageJ 1.53a software (National Institutes of Health) and normalized to GAPDH expression.
Statistical analysis.
All data are presented as the mean ± SD of ≥3 independent experiments. GraphPad Prism 8.0 software (GraphPad Software, Inc.) was used to perform the statistical analyses. One‑way ANOVA followed by Tukey's post hoc test was performed to compare differences among groups. P< 0.05 was considered to indicate a statistically significant difference.

Results



explore whether Rg1 alleviates aging‑related liver fibrosis, collagen deposition was measured in liver tissues by using Masson's staining. The results showed that the blue positive areas were significantly increased in the liver tissues of the SAMP8 group compared with the SAMR1 group (Fig. 2A and B). However, compared with the SAMP8 model group, the levels of collagen deposition were significantly reduced in the tempol, apocynin and Rg1 (5 and 10 mg/kg) treatment groups (Fig. 2A and B). In addition, the expression levels of collagen IV and TGF‑β1 were measured in liver tissues by using immunohistochemical staining.
The results of the collagen IV stainings revealed that collagen IV was expressed at low levels in the liver tissues in the SAMR1 group(Fig. 3A and C). However, compared with the SAMR1 group,
Rg1 treatment reduces ROS production and NOX4 expression in the liver of SAMP8 mice. ROS is an important factor in the development of hepatic fifibrosis (41). In the present study,a ROS probe, DHE, was used to detect the level of ROS production in liver tissues. The results showed that there were low levels of ROS production in the liver tissues of the SAMR1 group. However, compared with the SAMR1 group,the levels of ROS production were significantly increased in the SAMP8 group (Fig. 4A and B), while compared with the SAMP8 group, tempol, apocynin and Rg1 (5 and 10 mg/kg) treatment significantly reduced the levels of ROS production in the liver tissues (Fig. 4A and B). To confirm the effect of NOX4 on ROS accumulation during aging, the expression levels of NOX4‑related proteins were analyzed. The results demonstrated that, compared with the SAMR1 group, the expression levels of NOX4, p22phox and p47phox in the liver tissues were significantly upregulated in the SAMP8 group (Fig. 5A‑D).
However, compared with the SAMP8 group, tempol, apocynin and Rg1 (5 and 10 mg/kg) treatment significantly downregulated the expression levels of NOX4, p22phox and p47phox in liver tissues during aging (Fig. 5A‑D). These data suggested that Rg1 treatment may ameliorate ROS‑induced oxidative stress injury in liver tissues by inhibiting NOX4 during aging in mice.






